Antidiabetic Potiential of Moringa and Dom Extract

Diabetes Clinical Trial

Official title:

Antidiabetic Potential of Hyphanea Thebaica Fruits and Moringa Olifera Leaves

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05898750
• Other study ID #: MorDom
• Status: Completed
• Phase: Early Phase 1
• Start date: April 22, 2023
• Est. completion date: June 30, 2023

Study information

• Verified date: September 2023
• Source: Deraya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Antidiabetic potential of Hyphaene thebaica fruits and Moringa oleifera leaves will be investigated in diabetic patients (type 2). The patients will be maintained on tea of both drugs for 6 weeks. The fasting blood glucose levels of patients will be checked on a daily basis. Other blood biomarkers will be also reported such as insulin concentration, Lipid profile, liver enzymes, c-peptide and glycated hemoglobin

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: June 30, 2023
• Est. primary completion date: June 22, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years to 55 Years

Eligibility

Inclusion Criteria:

• diabetic patients type 2

Exclusion Criteria:

• liver failure

• heart failure

• renal failure

Related Conditions & MeSH terms

• Diabetes

Intervention

Dietary Supplement:
• MorDom
oral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)

Locations

Country	Name	City	State
Egypt	Soad A. Mohamad	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Deraya University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood glucose level	measured by fast blood test	3 months
Secondary	blood level of lipid profile	Blood samples were drawn to measure levels of LDL, HDL, triglycerides, total cholesterol	two weeks
Secondary	Liver enzymes	Blood samples were drawn to measure levels of ALT and AST	two weeks
Secondary	C-peptide level	Blood samples were drawn to measure fasting and postprandial levels of c-peptide	two weeks
Secondary	Insulin level	Blood samples were drawn to measure fasting and postprandial levels of insulin	two weeks